English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Caitlin Nordahl
| Jan 29, 2016
CBO report showing future increases in Medicare spending spurs health care reform proposals
Caitlin Nordahl
| Jan 29, 2016
FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
Caitlin Nordahl
| Jan 29, 2016
FDA accepts Merck's application for C. difficile infection reoccurrence prevention drug
Caitlin Nordahl
| Jan 29, 2016
STRIVE Trial shows increased progression-free survival for men with CRPC
Caitlin Nordahl
| Jan 29, 2016
LUX-Lung 7 trial compares two cancer therapies' effectiveness of progression-free survival
Ruth de Jauregui
| Jan 28, 2016
European Commission approves continued use of ambroxol, bromhexine products
Amanda Rupp
| Jan 28, 2016
AAFP seeks to add preconception care to patient visits
Kasey Schefflin- Emrich
| Jan 28, 2016
FDA approves Cosentyx as treatment for two inflammatory conditions
Trending
Patient Daily
| Nov 5, 2025
Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+
Pharmaceuticals
Patient Daily
| Nov 6, 2025
Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
+
Regulatory
Patient Daily
| Nov 6, 2025
Executive Director of Patients Come First on lawsuit ads: ‘One of the most pervasive and least regulated forces in consumer media’
Patient Daily
| Nov 5, 2025
Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
« First
«
…
249
250
251
252
253
254
255
…
»
Last »